Acelyrin, Inc (NASDAQ:SLRN) Receives $23 67 Average Target Price from Brokerages theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Shares of RayzeBio, Inc. (NASDAQ:RYZB – Get Free Report) reached a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $62.10 and last traded at $61.43, with a volume of 2066375 shares changing hands. The stock had previously closed at $30.57. Wall Street Analysts Forecast Growth Several equities analysts […]
Elevation Oncology, Inc. (NASDAQ:ELEV – Get Free Report) was the recipient of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 593,500 shares, a decline of 10.8% from the November 15th total of 665,100 shares. Based on an average daily trading volume, of 218,500 […]
Wells Fargo & Company initiated coverage on shares of Acelyrin (NASDAQ:SLRN – Free Report) in a research report sent to investors on Wednesday morning, MarketBeat.com reports. The brokerage issued an equal weight rating and a $11.00 price objective on the stock. A number of other analysts also recently commented on the stock. Citigroup assumed coverage […]
HC Wainwright restated their buy rating on shares of Acelyrin (NASDAQ:SLRN – Free Report) in a research report sent to investors on Tuesday morning, Benzinga reports. HC Wainwright currently has a $30.00 price objective on the stock. Separately, Morgan Stanley lowered Acelyrin from an overweight rating to an equal weight rating and lowered their price […]